Consumer Driven Health Care

In the United States, we acknowledge one unfortunate fact about health care: cost does not equate to quality.

Legislation limiting a provider's ability to negotiate prices could ultimately result in reduced access to care for consumers.

The costs and benefits of Medicare For All are hotly debated. Here are some key flashpoints.

Pharma and specialty drugs are among the top targets of employers attempting to rein in their health care spending. But what's the best approach?

Attendees of the recent Q4Live conference in San Diego discussed realistic and actionable ways to address the quality and cost of their clients' benefits plans.

The National Survey on Drug Use and Health released by the Substance Abuse and Mental Health Services Administration has some promising statistics.